Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Building out policies to properly regulate and integrate artificial intelligence in healthcare is now a core focus of medtech authorities. October was a particularly active month, with key publications from the UK, US, South Korea, and the International Medical Device Regulators Forum.
Pathology is moving from a laboratory discipline of microscopic discernment to one centered around data-rich digital images and AI. In the process, it’s becoming the specialty most able to drive precision medicine into the future. Insights from digital pathology company Proscia.
The Department of Commerce launches an investigation into device imports that could lead to more tariffs. Excerpted from Pathways’ Picks October 1: US Government Shutdown, Tariff Inquiry, AI Actions, and Global Picks.